Inventor · disambiguated record
Raj Haldankar
Also filed as: HALDANKAR RAJ
11 granted patents·4 pending applications·121 citations·filing 2014–2022
91Inventor score
Files withNGM BIOPHARMACEUTICALS INC15
Top patents by PatentIndex Score
15 records- 0197US9161966B2GDF15 mutein polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2015·29 cites·25 claims
- 0296US9827291B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·16 cites·46 claims
- 0395US9920118B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Mar 20, 2018·19 cites·34 claims
- 0494US9834586B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·18 cites·61 claims
- 0592US10610568B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·5 cites·37 claims
- 0692US9828415B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2014·Granted Nov 28, 2017·17 cites·46 claims
- 0790US11358995B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 14, 2022·2 cites·33 claims
- 0890US10323075B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 18, 2019·8 cites·34 claims
- 0989US11530260B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·2 cites·44 claims
- 1088US10562965B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Feb 18, 2020·5 cites·39 claims
- 1182US12173060B2Compositions and methods of use for treating metabolic disordersNGM BIOPHARMACEUTICALS INC·Filed 2022·Granted Dec 24, 2024·0 cites·23 claims
- 1270US2021388047A1Compositions and Methods of Use for Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1361US2020087366A1Compositions and Methods of Use For Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1459US2022251241A1Htra1-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1553US2018134761A1Compositions and Methods of Use for Treating Metabolic DisordersNGM BIOPHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →